Please login to the form below

Not currently logged in


This page shows the latest Ryzodeg news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk growth takes a hit with China deal

Novo Nordisk growth takes a hit with China deal

Novo has announced that it was successful in getting all its insulin products onto the national formulary with the exception of Ryzodeg and Xultophy. ... Ryzodeg contains a combination of long acting insulin degludec – which Novo markets as Tresiba –

Latest news

More from news
Approximately 6 fully matching, plus 15 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...